About: Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural plant-derived oil with high levels of tasmanone. The company has a research collaboration agreement with James Cook University for experiments demonstrating the value of pre-conditioning biomass prior to distillation; Cesar for assessing the insecticidal activity of its molecules against a range of insect species; Advanced Molecular Technologies; CSIRO for a chemistry development process; the Department of Agriculture and Fisheries, Queensland Government for assessing activity against grain storage pests; Eurofins; Grain Research Development Corporation; Pacific Discovery Services; Purdue University; Southern Cross University for chemical analysis of natural products; University of Florida; and University of Technology. It serves animal health, crop protection, grain storage, public health, and consumer applications. The company was incorporated in 1995 and is based in Melbourne, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.01 (-7.14%)
BGT ASX Bio-Gene Technology Ltd
Bio-Gene Technology Ltd share price
Atividade de preço de BGT
Último preço
$ 0,010
Variação (24h)
-0,00 AUD (7,14%)
Volume
83.30K
Volume (média 4 sem.)
-
Abertura
$ 0,01
Variação do dia
$ 0,01 - $ 0,01
Fechamento anterior
$ 0,01
Último negócio
03 Nov, 3:23 am GMT+0
Atrasado
03 Nov, 3:23 am GMT+0
BGT price performance
Atrasado
03 Nov, 3:23 am GMT+0
BGT details
quote.marketSignals